Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 480

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Discovery of a First-in-Class Receptor Interacting Protein 1 (RIP1) Kinase Specific Clinical Candidate (GSK2982772) for the Treatment of Inflammatory Diseases

Open access
Harris, Philip A., Berger, Scott B., Jeong, Jae U., Nagilla, Rakesh, Bandyopadhyay, Deepak, Campobasso, Nino, Capriotti, Carol A., Cox, Julie A., Dare, Lauren, Dong, Xiaoyang, Eidam, Patrick M., Finger, Joshua N., Hoffman, Sandra J., Kang, James, Kasparcova, Viera, King, Bryan W., Lehr, Ruth, Lan, Yunfeng, Leister, Lara K., Lich, John D., MacDonald, Thomas T., Miller, Nathan A., Ouellette, Michael T., Pao, Christina S., Rahman, Attiq, Reilly, Michael A., Rendina, Alan R., Rivera, Elizabeth J., Schaeffer, Michelle C., Sehon, Clark A., Singhaus, Robert R., Sun, Helen H., Swift, Barbara A., Totoritis, Rachel D., Vossenkämper, Anna, Ward, Paris, Wisnoski, David D., Zhang, Daohua, Marquis, Robert W., Gough, Peter J., Bertin, John · 2017 · Journal of Medicinal Chemistry

Abstract

RIP1 regulates necroptosis and inflammation and may play an important role in contributing to a variety of human pathologies, including immune-mediated inflammatory diseases. Small-molecule inhibitors of RIP1 kinase that are suitable for advancement into the clinic have yet to be described. Herein, we report our lead optimization of a benzoxazepinone hit from a DNA-encoded library and the discovery and profile of clinical candidate GSK2982772 (compound 5), currently in phase 2a clinical studies for psoriasis, rheumatoid arthritis, and ulcerative colitis. Compound 5 potently binds to RIP1 with exquisite kinase specificity and has excellent activity in blocking many TNF-dependent cellular responses. Highlighting its potential as a novel anti-inflammatory agent, the inhibitor was also able to reduce spontaneous production of cytokines from human ulcerative colitis explants. The highly favorable physicochemical and ADMET properties of 5, combined with high potency, led to a predicted low oral dose in humans.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1021/acs.jmedchem.6b01751

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 3

  1. 10.1038/cddis.2012.64 · DOI · Paper page
  2. 10.1021/ja506518t · doi:10.1021/ja506518t
  3. Katritzky A. R., 2010, Handbook of Heterocyclic Chemistry, 149

Cited by

See all 480

Metadata

Authors
Harris, P. A., Berger, S. B., Jeong, J. U., Nagilla, R., Bandyopadhyay, D., Campobasso, N., Capriotti, C. A., Cox, J. A., Dare, L., Dong, X., Eidam, P. M., Finger, J. N., Hoffman, S. J., Kang, J., Kasparcova, V., King, B. W., Lehr, R., Lan, Y., Leister, L. K., Lich, J. D., MacDonald, T. T., Miller, N. A., Ouellette, M. T., Pao, C. S., Rahman, A., Reilly, M. A., Rendina, A. R., Rivera, E. J., Schaeffer, M. C., Sehon, C. A., Singhaus, R. R., Sun, H. H., Swift, B. A., Totoritis, R. D., Vossenkämper, A., Ward, P., Wisnoski, D. D., Zhang, D., Marquis, R. W., Gough, P. J., & Bertin, J.
Venue
Journal of Medicinal Chemistry
Published
2017-02-10
Volume
60
Issue
4
Pages
1247-1261
ISSN
  • 0022-2623 (ISSN-L)
  • 1520-4804
OpenAlex
W2584580415
Cited by
480
References
28
FWCI
14.85
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.